CTLA4 Detection Set (Risk Free), IgG1, Unconjugated, Mouse, Monoclonal

Catalog Number: PRS-RF16010
Article Name: CTLA4 Detection Set (Risk Free), IgG1, Unconjugated, Mouse, Monoclonal
Biozol Catalog Number: PRS-RF16010
Supplier Catalog Number: RF16010
Alternative Catalog Number: PRS-RF16010-1
Manufacturer: ProSci
Host: Mouse
Category: Antikörper
Application: ELISA, FC, ICC, IF, IHC-P, WB
Species Reactivity: Human
Immunogen: Mouse monoclonal CTLA-4 antibodies were raised against the extracellular domain of human CTLA-4.
Conjugation: Unconjugated
Clonality: Monoclonal
Concentration: Antibody 1 mg/mL
Isotype: IgG1
Buffer: PBS containing 0.02% sodium azide.
Form: Liquid
Application Dilute: Optimal dilutions for each application to be determined by the researcher.
Titration curve analysis of CTLA-4 mAbs to detect recombinant CTLA-4 in ELISA with RF16011, RF16012, and RF16013 antibodies at decreasing concentrations.
A sandwich ELISA was performed using the anti-CTLA-4 mAbs RF16011, RF16012, RF16013, as the capture antibodies for the CTLA-4 extracellular domain antigen with HRP-labeled Risk-Free anti-CTLA-4 mAbs as the detection antibodies.
Immunocytochemistry of CTLA-4 in overexpressing 293 cells using (A) RF16011, (B) RF16012, (C) RF16013, and (D) control mouse IgG antibody at 5 &956,g/ml.
Immunofluorescence of CTLA-4 in overexpressing 293 cells using (A) RF16011, (B) RF16012, (C) RF16013, and (D) control mouse IgG antibody at 20 &956,g/ml.
Immunofluorescence of CTLA-4 in human tonsil tissue using (A) RF16011, (B) RF16012, (C) RF16013, and (D) control mouse IgG antibody at at 20 &956,g/ml.
Immunohistochemistry of CTLA-4 in human lymph node tissue using (A) RF16011, (B) RF16012, (C) RF16013 and (D) control mouse IgG antibody at 5 &956,g/ml.
Immunohistochemistry of CTLA-4 in human tonsil tissue using (A) RF16011, (B) RF16012, (C) RF16013 and (D) control mouse IgG antibody at 5 &956,g/ml.
Western blot analysis of CTLA-4 in overexpressing 293 cells using RF16011, RF16012, and RF16013 antibody at 1, 0.5, and 0.25 &956,g/ml, respectively.